SIA
VSTM icon

SkyView Investment Advisors’s Verastem VSTM Stock Holding History

SkyView Investment Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,083
Closed -$77K – 589
2021
Q3 		$77K Buy
+2,083
New +$76.5K 0.02% 352

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

SkyView Investment Advisors's VSTM Position: Q4 2021 in Review

SkyView Investment Advisors sold out of Verastem (VSTM) in Q4 2021, closing a stake of 2,083 shares — an estimated $77K sold.

SkyView Investment Advisors first reported a position in VSTM in Q3 2021 and held it in 1 quarter. The position peaked at $77K in Q3 2021. 153 funds tracked by Wall St. Rank hold VSTM as of Q4 2021.

  • SkyView Investment Advisors reported no remaining Verastem position as of Q4 2021 after selling out during the quarter.
  • SkyView Investment Advisors sold 2,083 Verastem shares in Q4 2021, an estimated $77K.
  • SkyView Investment Advisors first reported a position in Verastem in Q3 2021 and held it in 1 quarter.
  • SkyView Investment Advisors's Verastem position peaked at $77K in Q3 2021.
  • 153 funds tracked by Wall St. Rank held Verastem as of Q4 2021.

Based on SkyView Investment Advisors's 13F filing for Q4 2021, filed 18 Feb 2022.